Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome

نویسندگان

  • Neha Pangasa
  • Rohan Magoon
  • Vandana Bhardwaj
  • Amita Sharma
  • Ameya Karonjkar
  • Poonam Malhotra Kapoor
چکیده

First, in the author’s study methylene blue was administered in a dose of 1–2 mg/kg bolus over 10 min and the median time until a maximum hemodynamic response was 2 h after drug administration. Out of 88 patients who received methylene blue, only 39 (44.3%) showed a positive hemodynamic response to the drug. We believe that if the bolus of methylene blue was followed by a continuous infusion of the drug, it would have produced even better results. Evora et al. have reviewed 20 years of vasoplegic syndrome treatment in heart surgery and found that the most used dosage of methylene blue is 2 mg/kg as an intravenous bolus, followed by the same dose in continuous infusion because its plasma concentration sharply decreases in the first 40 min.[2,3]

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Vasoplegic syndrome--the role of methylene blue.

Vasoplegic syndrome is a recognized complication following cardiac surgery using cardiopulmonary bypass and is associated with increased morbidity and mortality. In several patients profound post-operative vasodilatation does not respond to conventional vasoconstrictor therapy. Methylene blue has been advocated as an adjunct to conventional vasoconstrictors in such situations. There is limited ...

متن کامل

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery

Vasoplegic syndrome is a well-recognized complication during cardiopulmonary bypass (CPB) and is associated with increased morbidity and mortality, especially when refractory to conventional vasoconstrictor therapy. This is the first reported case of vasoplegia on CPB unresponsive to methylene blue whereas responsive to hydroxocobalamin, which indicates that the effect of hydroxocobalamin outsi...

متن کامل

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study

BACKGROUND Methylene blue (MB) has been used to treat refractory hypotension in a variety of settings. AIMS We sought to determine whether MB improved blood pressure in postcardiopulmonary bypass (CPB) vasoplegic syndrome (VS) in a complex cardiac surgery population. Furthermore, to determine variables that predicted response to MB. SETTING AND DESIGN This was conducted in a tertiary care m...

متن کامل

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue

Methylene blue is a phenothiazine-related heterocyclic aromatic molecule presently used in the treatment of methemoglobinemia. Recently, it has been implicated in the treatment of severe refractory vasoplegic shock caused by anaphylaxis, sepsis, or postcardiopulmonary bypass. We present a case of a 27-year-old male with profound vasoplegic shock of unknown etiology which was refractory to vasop...

متن کامل

Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.

Protamine sulfate is used during coronary artery bypass graft surgery to reverse the anticoagulating effects of heparin. Vasoplegic syndrome is a state of endothelial dysregulation that produces profound vasodilatation that is refractory to vasopressors. This syndrome leads to systemic hypoperfusion and may progress to death. Up to 27% of patients after cardiac bypass may experience vasoplegia....

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 20  شماره 

صفحات  -

تاریخ انتشار 2017